Clinical parameters associated with collateral development in patients with chronic total coronary occlusion

Heart. 2013 Aug;99(15):1100-5. doi: 10.1136/heartjnl-2013-304006. Epub 2013 May 28.

Abstract

Objective: Well-developed collaterals provide survival benefit in patients with obstructive coronary artery disease (CAD). Therefore, in this study we sought to determine which clinical variables are associated with arteriogenesis.

Design: Clinical and laboratory variables were collected before percutaneous coronary intervention. Multivariate analysis was performed to determine which variables are associated with the collateral flow index (CFI).

Patients: Data from 295 chronic total occlusion (CTO) patients (Bern, Switzerland, Amsterdam, the Netherlands and Jena, Germany) were pooled. In earlier studies, patients had varying degrees of stenosis. Therefore, different stages of development of the collaterals were used. In our study, a unique group of patients with CTO was analysed.

Interventions: Instead of angiography used earlier, we used a more accurate method to determine CFI using intracoronary pressure measurements. CFI was calculated from the occlusive pressure distal of the coronary lesion, the aortic pressure and central venous pressure.

Results: The mean CFI was 0.39 ± 0.14. After multivariate analysis, β blockers, hypertension and angina pectoris duration were positively associated with CFI (B: correlation coefficient β=0.07, SE=0.03, p=0.02, B=0.040, SE=0.02, p=0.042 and B=0.001, SE=0.000, p=0.02). Furthermore also after multivariate analysis, high serum leucocytes, prior myocardial infarction and high diastolic blood pressure were negatively associated with CFI (B=-0.01, SE=0.005, p=0.03, B=-0.04, SE=0.02, p=0.03 and B=-0.002, SE=0.001, p=0.011).

Conclusions: In this unique cohort, high serum leucocytes and high diastolic blood pressure are associated with poorly developed collaterals. Interestingly, the use of β blockers is associated with well-developed collaterals, shedding new light on the potential action mode of this drug in patients with CAD.

Keywords: CORONARY ARTERY DISEASE.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Arterial Pressure
  • Central Venous Pressure
  • Cohort Studies
  • Collateral Circulation*
  • Comorbidity
  • Coronary Circulation*
  • Coronary Occlusion* / diagnosis
  • Coronary Occlusion* / epidemiology
  • Coronary Occlusion* / physiopathology
  • Coronary Occlusion* / therapy
  • Coronary Vessels / physiopathology
  • Diagnostic Techniques, Cardiovascular
  • Female
  • Germany / epidemiology
  • Humans
  • Hypertension* / complications
  • Hypertension* / epidemiology
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Netherlands / epidemiology
  • Percutaneous Coronary Intervention / methods
  • Perioperative Care / methods
  • Perioperative Care / statistics & numerical data
  • Severity of Illness Index
  • Statistics as Topic
  • Switzerland / epidemiology

Substances

  • Adrenergic beta-Antagonists